TIM‐4 increases the proportion of CD4+CD25+FOXP3+ regulatory T cells in the pancreatic ductal adenocarcinoma microenvironment by inhibiting IL‐6 secretion
Abstract Background Currently, creating more effector T cells and augmenting their functions is a focal point in pancreatic ductal adenocarcinoma (PDAC) treatment research. T cell immunoglobulin domain and mucin domain molecule 4 (TIM‐4), known for promoting cancer progression in various malignancie...
Saved in:
Main Authors: | Ziyao Wang, Zerong Xie, Yu Mou, Ruiman Geng, Chen Chen, Nengwen Ke |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-09-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.70110 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IRG1/itaconate enhances efferocytosis by activating Nrf2-TIM4 signaling pathway to alleviate con A induced autoimmune liver injury
by: Liwu Zeng, et al.
Published: (2025-02-01) -
Differential expression of CD175 and CA19-9 in pancreatic adenocarcinoma
by: Jane J. Cheng, et al.
Published: (2025-02-01) -
Selective epithelial expression of KRASG12D in the Oncopig pancreas drives ductal proliferation and desmoplasia that is accompanied by an immune response
by: Carlos P. Jara, et al.
Published: (2025-02-01) -
CD4 expression controls epidermal stem cell balance
by: Nadine Brandes, et al.
Published: (2025-02-01) -
Single-cell landscape of dynamic changes in CD8+ T cells, CD4+ T cells and exhausted T cells in hepatocellular carcinoma
by: Rongqiang Liu, et al.
Published: (2025-02-01)